Literature DB >> 19449376

Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis.

Chien-Hung Lee1, Deng-Chyang Wu, I-Chen Wu, Yih-Gang Goan, Jang-Ming Lee, Shah-Hwa Chou, Te-Fu Chan, Hsiao-Ling Huang, Yu-Hsiu Hung, Meng-Chuan Huang, Tai-Cheng Lai, Tsu-Nai Wang, Cheng-Che E Lan, Sharon Tsai, Wen-Yi Lin, Ming-Tsang Wu.   

Abstract

Genetic variants in alcohol dehydrogenase-1B (ADH1B) and aldehyde dehydrogenase-2 (ALDH2) genes modulate acetaldehyde removal upon alcohol ingestion. Although these genetic vulnerabilities have been linked to higher esophageal squamous cell carcinoma (ESCC) risks, it is unclear whether they also determine the time of malignancy presentation. The purpose of this investigation was to unravel genotoxic effects of the two alcohol-metabolizing genes with regard to alcohol and tobacco consumption on the age at ESCC diagnosis and tumor dissemination. ADH1B/ALDH2 genotyping was performed on lymphocyte DNA specimens taken from 406 consecutively registered incident patients with pathology-proven ESCC. To fully utilize individual genetic and survival information, survival analyses and gene-longevity applied approaches were introduced. Among heavy drinkers, the ADH1B Arg/Arg (55 years) and ALDH2 Glu/Lys genotypes (54 years) were found to confer a 15 and 16 years earlier carcinoma diagnosed age than His/His and Glu/Glu nondrinkers (both 70 years), respectively. For drinkers, 1-year age advancement was, separately, associated with a 0.977 and 0.953-fold stepwise reduced likelihood of being ADH1B Arg homozygote and ALDH2 Lys variant. Noticeably elevated hazard-ratio (HR) for drinkers of ADH1B slow-form genotype and ALDH2 inactive-form allele were identified in smokers (HR = 2.3-2.6), but no in nonsmokers. In smokers, appreciably higher cumulative cancer onset risks were correspondingly recognized from the age of 45 and 49 upward among any + Lys allele and Arg/Arg + Glu/Glu combined-ADH1B/ALDH2-genotype drinkers than nondrinkers. In conclusion, consumption of tobacco and alcohol, coupled with genetic susceptibilities associated with acetaldehyde elimination, as modulated by ADH1B and ALDH2 genotypes, determines a substantial magnitude of tumorigenetic effect on earlier age ESCC diagnosis. 2009 UICC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449376     DOI: 10.1002/ijc.24357

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of esophageal squamous cell carcinoma.

Authors:  Zhanjun Guo; Hua Yang; Fengbin Zhang; Ruixing Zhang; Cuiju Wang
Journal:  Oncol Lett       Date:  2011-11-25       Impact factor: 2.967

Review 2.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

3.  Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.

Authors:  Yuki Matsumura; Na Li; Hanan Alwaseem; Odelya E Pagovich; Ronald G Crystal; Matthew B Greenblatt; Katie M Stiles
Journal:  Hum Gene Ther       Date:  2020-01-28       Impact factor: 5.695

4.  Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study.

Authors:  Zihui Tan; Hong Yang; Jing Wen; Kongjia Luo; Qianwen Liu; Yihuai Hu; Lanjun Zhang; Mengzhong Liu; Jingping Yun; Jianhua Fu
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 5.  Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency.

Authors:  Rachel A Montel; Carlos Munoz-Zuluaga; Katie M Stiles; Ronald G Crystal
Journal:  Cancer Gene Ther       Date:  2021-11-19       Impact factor: 5.854

6.  Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma.

Authors:  Yu-Kuei Chen; Chun-Wei Tung; Jui-Ying Lee; Yi-Chun Hung; Chien-Hung Lee; Shah-Hwa Chou; Hung-Shun Lin; Ming-Tsang Wu; I-Chen Wu
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

7.  Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma.

Authors:  Peng Sun; Cui Chen; Fei Zhang; Hang Yang; Xi-Wen Bi; Xin An; Feng-Hua Wang; Wen-Qi Jiang
Journal:  Onco Targets Ther       Date:  2016-07-13       Impact factor: 4.147

8.  Impact of alcohol consumption on survival in patients with esophageal carcinoma: a large cohort with long-term follow-up.

Authors:  Qingyuan Huang; Kongjia Luo; Hong Yang; Jing Wen; Shuishen Zhang; Jinhui Li; Amos Ela Bella; Qianwen Liu; Fu Yang; Yuzhen Zheng; Ronggui Hu; Junying Chen; Jianhua Fu
Journal:  Cancer Sci       Date:  2014-11-11       Impact factor: 6.716

9.  Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis.

Authors:  Ning Mao; Siyao Nie; Bin Hong; Chao Li; Xueyuan Shen; Tao Xiong
Journal:  World J Surg Oncol       Date:  2016-07-22       Impact factor: 2.754

10.  Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.

Authors:  Marie-Pier Tremblay; Victoria E S Armero; Andréa Allaire; Simon Boudreault; Camille Martenon-Brodeur; Mathieu Durand; Elvy Lapointe; Philippe Thibault; Maude Tremblay-Létourneau; Jean-Pierre Perreault; Michelle S Scott; Martin Bisaillon
Journal:  BMC Genomics       Date:  2016-08-26       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.